Outcomes of patients who progressed while receiving avelumab + axitinib (A + Ax) and received subsequent treatment (Tx) in JAVELIN Renal 101 Meeting Abstract


Authors: Albiges, L.; Voss, M. H.; Rini, B. I.; Gravis, G.; Grimm, M. O.; Nathan, P. D.; Bjarnason, G. A.; Tomita, Y.; Penkov, K.; McGregor, B.; Huang, B.; Thomaidou, D.; Mariani, M.; Di Pietro, A.; Choueiri, T. K.
Abstract Title: Outcomes of patients who progressed while receiving avelumab + axitinib (A + Ax) and received subsequent treatment (Tx) in JAVELIN Renal 101
Meeting Title: 2021 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 39
Issue: 15 Suppl.
Meeting Dates: 2021 Jun 4-8
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2021-05-20
Language: English
ACCESSION: WOS:000708120602262
DOI: 10.1200/JCO.2021.39.15_suppl.4514
PROVIDER: wos
Notes: Meeting Abstract: 4514 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Henner Voss
    288 Voss